Current perspective on allergen immunotherapy for food allergies

Area of Science:

• Immunology
• Allergy Research
• Clinical Trials

Background:

• Food allergies present a growing global health challenge, impacting quality of life and requiring strict allergen avoidance.
• Current management relies on avoidance and emergency medications, but new therapeutic strategies are emerging.

Purpose of the Study:

• To review current perspectives on allergen immunotherapy for food allergy treatment.
• To focus on evidence and practices related to oral immunotherapy (OIT) in Japan.

Main Methods:

• Review of clinical trials and reported studies on food allergen immunotherapy (AIT).
• Focus on oral immunotherapy (OIT), epicutaneous immunotherapy (EPIT), and sublingual immunotherapy (SLIT).
• Comparison of OIT practices in Japan versus Europe and the US.

Main Results:

• Clinical trials demonstrate AIT's efficacy in increasing reaction thresholds and achieving desensitization.
• The first FDA approval for peanut OIT marks a significant therapeutic milestone.
• Over 100 facilities in Japan conduct OIT, with distinct protocols compared to Western countries.

Conclusions:

• Allergen immunotherapy represents a significant advancement in treating food allergies.
• Safer, more effective approaches, including adjunct treatments and allergen modifications, are under investigation.
• Japanese OIT practices, including separate oral food challenges, offer unique insights into AIT management.